首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients.
【24h】

Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients.

机译:甲状腺功能亢进的格雷夫斯病患者的颈总动脉僵硬度增加。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The present study was undertaken to assess the effect of hyperthyroidism on stiffness in the common carotid artery (CCA) in patients with Graves' disease (GD) and elucidate the mechanism by which arterial stiffness is increased in hyperthyroidism. The arterial stiffness index beta (stiffness beta) was evaluated in the CCA using an ultrasonic phase-locked echo-tracking system. Stiffness beta was defined as the logarithm of the ratio of systolic to diastolic blood pressure divided by the fractional diameter increase during the cardiac cycle and thus established as a measure of arterial stiffness uninfluenced by the change in blood pressure. Seventy euthyroid GD patients were measured for CCA stiffness beta to determine its relationship to retinal blood flow and plasma levels of vascular injury markers. To investigate the effect of hyperthyroidism, 27 GD patients were measured for changes during antithyroid drug (ATD) therapy in stiffness beta and in hemodynamic parameters, retinal blood flow and plasma vascular injury markers. In euthyroid GD patients, stiffness beta in the CCA showed a significant and positive correlation with systolic blood pressure and pulse pressure, but not with peripheral blood flow in the central retinal artery. ATD therapy significantly reduced stiffness beta from 5.23 +/- 2.10 to 4.36 +/- 1.48. The fractional reduction of stiffness beta during ATD therapy correlated significantly with reductions in pulse pressure and retinal blood flow, but not with the reductions in systolic and mean blood pressure, or any of the plasma injury markers. In summary, the significant increase in stiffness beta in the hyperthyroid state may reflect the harmful effect of hyperthyroidism on the arterial wall, which may in turn result from increased stroke volume.
机译:本研究旨在评估甲亢对Graves病(GD)患者颈总动脉(CCA)僵硬的影响,并阐明甲亢中动脉僵硬增加的机制。使用超声锁相回波跟踪系统在CCA中评估动脉僵硬度指数β(刚度β)。刚度β定义为收缩压与舒张压之比的对数除以心动周期中直径的分数增加,因此被确定为不受血压变化影响的动脉刚度的量度。测量了70名甲状腺功能正常的GD患者的CCA硬度β,以确定其与视网膜血流量和血浆中血管损伤标志物水平的关系。为了研究甲状腺功能亢进症的影响,对27名GD患者进行了抗甲状腺药物(ATD)治疗期间的僵硬度β以及血液动力学参数,视网膜血流和血浆血管损伤标志物的变化测量。在甲状腺功能正常的GD患者中,CCA的僵硬性β与收缩压和脉压呈显着正相关,而与视网膜中央动脉的外周血流则无显着正相关。 ATD治疗将僵硬度β从5.23 +/- 2.10显着降低到4.36 +/- 1.48。在ATD治疗期间,僵硬性β的分数降低与脉压和视网膜血流的降低显着相关,但与收缩压和平均血压或任何血浆损伤标志物的降低却没有显着相关。总而言之,甲状腺功能亢进状态下僵硬度β的显着增加可能反映了甲状腺功能亢进对动脉壁的有害影响,这可能又是由于卒中量增加所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号